The Future Development Trend of My Country's Veterinary Drug Industry

Over the past 30 years of reform and opening up, my country's animal husbandry has developed rapidly, from traditional animal husbandry to modern animal husbandry from standardization to intensive, intensive, and large-scale development. In the transition from traditional animal husbandry to modernization, the veterinary drug industry is also showing new trends. The development of animal husbandry promotes the development of Veterinary Company

Atropine Injection

The veterinary medicine industry directly serves the animal husbandry, and the continuous development of the animal husbandry has driven the development of the veterinary medicine industry. my country is a big country in animal husbandry, with a large number of economic animal breeding groups, and a strong demand for veterinary drugs. The breeding scale of economic animals in my country ranks among the top in the world, and the output of meat, poultry and eggs has ranked first in the world for many years. Therefore, the market scale and development of the animal husbandry industry will directly determine the growth of market demand for the veterinary drug industry.

At present, the development of my country's veterinary drug industry has begun to take shape, with 457 enterprises above designated size and an output value of over 90 billion yuan. From 2006 to 2016, the compound annual growth rate of the total industrial output value of my country's veterinary drug industry reached 18.28%, becoming one of the fastest growing countries in my country's veterinary drug industry.

It is changing from agriculture to standardization, intensive and large-scale. Large-scale agriculture. The gradual increase in the proportion of large-scale breeding will greatly promote the animal husbandry's demand for veterinary drugs, and will be more conducive to large-scale, product quality improvement and the emphasis on win-win. Veterinary drug company.

In general, with changes in living standards and social structure, Veterinary Drugs Tablets have increased a lot of market demand. For example, the rapid development of special economic animals and pets has brought new space to the veterinary drug market. The increasing emphasis on food safety will also promote the rapid growth of demand for veterinary drugs. In this context, the veterinary drug industry can maintain an average growth rate of 10%-16% in the next few years, and it is still in a rapid growth stage.

First of all, as residents pay more and more attention to food safety, the country's veterinary drug use management and residue monitoring have also been continuously strengthened. Customers have shifted from the single pursuit of "efficiency" in the past to the focus on products "high efficiency, safety, low residue, and low toxicity". "Change. New animal vaccines, modern veterinary drugs, new drug preparations and other low-toxic, low-residue green drugs will gradually replace traditional veterinary drug products. Under the guidance of market demand adjustment and national policy supervision, efficient, safe, and low-residue drugs will Become the mainstream of the future veterinary drug market.

Second, the domestic livestock and poultry industry has long used monovalent vaccines that can only target one epidemic, and animal epidemics often show the characteristics of multiple mixed diseases. In order to better prevent and control epidemics, it is necessary to use multi-linked multivalent vaccines to vaccinate animals. The widespread use of multivalent and multivalent vaccines can not only reduce the immune density and pressure of livestock and poultry, but also greatly reduce the cost of drugs for livestock and poultry, thus becoming the development trend of veterinary vaccines. Vaccine-based biological veterinary drugs are growing rapidly, and their proportion will continue to rise.

Finally, as epidemic pathogen mutations and new diseases continue to increase, the prevention and control of animal epidemics in Animal Medicine will become more complicated and difficult, and the needs of customers will gradually change from simple disease treatment or epidemic prevention to systemic disease. Prevention and health care plan. Changes in customer demand not only require veterinary drug companies to provide higher-quality products, but also provide systematic animal disease solutions and advanced nutritional balance and feeding management solutions. In the future, the rationality of product structure and high-quality technical services will become the key elements of the core competitiveness of veterinary drug companies. Therefore, on the one hand, veterinary drug companies must enrich the varieties of veterinary drugs to cope with the increasingly complex diseases; on the other hand, they must continue to strengthen the breadth and depth of technical services.